Here's the short version. Sermorelin nudges your body to release more of its own growth hormone. That part works. Turning it into fat loss is where the evidence runs out. A small healthy-older-men study found no body-composition change [3].
A 12-week Geref trial in 31 men with HIV-associated lipodystrophy found lower trunk fat and higher lean mass as secondary endpoints. Total fat did not improve. This is not evidence of general obesity treatment [1].
What sermorelin is
Sermorelin is a lab-made copy of the first 29 amino acids of growth-hormone-releasing hormone (GHRH). It tells the pituitary gland to release your own growth hormone, rather than supplying the hormone itself.
It was once an FDA-approved brand, Geref, for children with growth hormone deficiency and for a pituitary test. The maker stopped selling it, FDA withdrew the approvals in 2009, and in 2013 FDA said the product wasn't pulled for safety or effectiveness reasons [8]. Today it reaches patients mainly through compounding pharmacies, and it isn't FDA-approved for weight loss or anything else.
Does sermorelin cause weight loss?
The cited adult study that measured body fat found no reduction. Six weeks of nightly sermorelin changed neither weight nor fat on a body scan.
The study enrolled 11 healthy, non-obese men aged 64 to 76 with low starting IGF-1, a growth-hormone marker. Night-time growth hormone release went up. But weight, BMI, waist-to-hip ratio and DXA measures of fat and lean tissue stayed the same. IGF-1 didn't change either [3].
Two caveats cut both ways. There was no placebo group, and the study was short. So it can't rule out a small effect over many months. It also gives no sign of one.
Notice who was studied, too. Both adult studies enrolled older men who weren't obese. The adult studies cited here do not establish weight-loss efficacy in women, younger adults or people with obesity.
An earlier study gave the same molecule twice a day for 14 days to 10 older men. At the higher amount tested, growth hormone and IGF-1 rose to levels seen in young men [4]. It didn't measure body fat or weight at all.
| Study | Drug | Who | Weight or fat result |
|---|---|---|---|
| Vittone 1997 [3] | Sermorelin (GHRH 1-29) | 11 healthy older men, 6 weeks, no placebo group | No change in weight, BMI, waist-to-hip ratio or DEXA fat |
| Corpas 1992 [4] | GHRH 1-29, twice daily | 10 older men, 14 days per dose level | Growth hormone and IGF-1 up at the higher amount; fat not measured |
| Falutz 2007 [5] | Tesamorelin (Egrifta), a different GHRH drug | 412 adults with HIV and belly-fat buildup, 26 weeks | Deep belly fat down 15.2% vs up 5.0% on placebo; label calls it "weight neutral" |
Tesamorelin is a separate, brand-only drug. Its results don't carry over to sermorelin.
Does sermorelin burn belly fat?
General weight-loss benefit is not established. Some widely cited belly-fat numbers come from tesamorelin, a different GHRH drug approved only for HIV-associated lipodystrophy.
In its main 26-week trial, tesamorelin cut deep belly (visceral) fat by 15.2%, while it rose 5.0% on placebo [5]. That's a real effect, in a specific group of people with HIV. Even so, the Egrifta SV label says it "is not indicated for weight loss management as it has a weight neutral effect" [7].
So the drug with the belly-fat data doesn't cause weight loss, while sermorelin has only limited population-specific body-composition findings. For more on tesamorelin and body composition, see does tesamorelin build muscle.
Does sermorelin increase or suppress appetite?
No published sermorelin trial reported appetite as an outcome, so neither claim has data behind it. A PubMed search for sermorelin or GHRH 1-29 with appetite, hunger or food intake turned up one 2026 review and no trials [6].
If your appetite changes on any new medicine, tell your prescriber. The related question for tesamorelin has its own page: does tesamorelin affect appetite.
Why sermorelin is marketed for fat loss
Growth hormone itself shifts body composition in people who lack it, so sellers extend that logic to sermorelin. The studies in healthy adults don't show it.
The chain goes: sermorelin raises growth hormone, growth hormone breaks down fat, so sermorelin must burn fat. Each step sounds fine. But in the six-week healthy-older-men study, fat didn't move [3]. A theory isn't a result, and this one hasn't been tested well.
If muscle is the real goal, that's a separate question with its own evidence: does sermorelin build muscle. The body composition shortlist covers options people use for that goal.
What's approved for weight loss
If weight is the goal, FDA has approved medicines for it. Wegovy, which is semaglutide, is approved with diet and exercise to reduce excess body weight and keep it off long term [10]. Zepbound, which is tirzepatide, carries the same kind of approval in adults [11].
The gap in evidence is large. In tirzepatide's main 72-week weight trial, average weight loss reached about 21% on the highest dose tested, against about 3% on placebo, in more than 2,500 adults [9]. Sermorelin has no trial of that kind at any size.
Both need a prescription and a prescriber who checks whether they fit you. Some people ask about pairing sermorelin with a GLP-1, and sermorelin and tirzepatide together covers what's known. The metabolic shortlist is the place to start comparing options.
If you're considering sermorelin anyway
Ask what outcome the prescriber expects and how it will be measured. A program that promises fat loss should be able to tell you what study that promise rests on.
For timing, read how long sermorelin takes to work. For access and price, see how to get sermorelin and what sermorelin costs. Your prescriber sets any dose and schedule.